ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

$ 16.50

4.5
(278)
In stock
Description

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half

San Francisco Biotech Networks on LinkedIn: All about hurricanes - San Francisco Biotechnology Network

Stock Market News 2023-12-18

PharmiWeb Recruiter Blog

ICLR, Detailed Quotes

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 - San Francisco Biotechnology Network

ICLR -- Is Its Stock Price A Worthy Investment? Learn More.

Stock Market News 2023-12-18

PharmiWeb Recruiter Blog

Quotazione azione ICON. ICLR - Quotazioni Azioni, Grafici, Storico dei trades, Forum Azioni, Bilanci